Oceanus 14 Pro, PTA balloon catheter receives CE Mark Approval
Barcelona, December 4th, 2017- Oceanus 14 Pro, PTA balloon catheter receives CE Mark Approval
iVascular is pleased to announce the release of the new Oceanus 14 Pro PTA balloon catheter, which has received CE Mark Approval to dilate stenoses in femoral, popliteal, and infrapopliteal arteries, and to treat obstructive lesions in arteriovenous dialysis fistulae.
Oceanus 14 Pro has been specifically elaborated to adapt to the market needs. Beyond its exceptional crossing profile and size range, including ultra-small diameters (1.25mm and 1.5mm) and lengths (10mm and 15mm), it is the only PTA catheter that adapts its number and type of radiopaque markers for enhanced visibility, flexibility and trackability:
1 tungsten radiopaque marker for the smallest and shortest balloons 2 tungsten radiopaque markers for smaller diameters and lengths over 20mm. 2 metallic radiopaque markers for other references.
“We are proud to bring to market the latest technology of PTA catheter. Our goal is to further develop technologies that will contribute to better long term clinical outcomes.” – said Lluis Duocastella, CEO of iVascular S.L.U.
iVascular S.L.U (www.ivascular.global) is a fast-growing company based in Barcelona that has developed exclusive technologies in a vertically integrated project to innovate and produce coronary and endovascular devices from basic raw materials to the final device or implant, including DCB, DES, SE nitinol stents, CoCr Bare Metal Stents, thrombus extractors and angioplasty balloons.